Grupa Azoty (ATT) Q4 2023 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2023 earnings summary
7 Nov, 2026Executive summary
Q4 2023 revenue fell 39.6% YoY to PLN 3,083m; EBITDA improved to a PLN 10m loss from a PLN 296m loss, while net loss widened to PLN 1,449m.
FY 2023 revenue declined 45.1% to PLN 13,545m; EBITDA swung to a PLN 1,366m loss from PLN 2,545m profit, and net loss reached PLN 3,290m.
Management identified restructuring and a recovery plan as principal priorities amid weak markets, organizational issues, and the absence of effective remedial measures in 2023.
Financial highlights
Q4 revenue was PLN 3,083m versus PLN 5,107m; EBITDA was -PLN 10m versus -PLN 296m, and EBIT was -PLN 1,647m versus -PLN 1,431m.
FY revenue was PLN 13,545m versus PLN 24,658m; capital expenditure was PLN 2,210m versus PLN 2,700m.
FY net loss was PLN 3,290m versus net profit of PLN 584m in 2022.
Q4 output declined YoY across several products, including nitrogen fertilizers (276k to 269k tonnes), compound fertilizers (187k to 158k tonnes), and polyamide (26k to 24k tonnes).
Outlook and guidance
Priorities include a recovery plan, an agreement with financial institutions, additional capital, a new business model, production profitability improvements, and stronger business synergies.
The Polimery Police schedule targeted a full-load run and commercial operation in H1 2024; production remained in start-up, test runs, and guaranteed-performance testing as of April 2024.
Further priorities include full commercial launch of Polimery Police, ESG implementation, a group decarbonisation strategy, and review of plant condition.
Latest events from Grupa Azoty
- Sales grew, but losses, market headwinds and financing uncertainty persisted.ATT
Q1 2025 - Q3 rebounded on a one-off settlement, but losses and financing risks persist.ATT
Q3 2025 - Agro-led EBITDA recovery paired with GAP restructuring targets a sharp debt reduction.ATT
Q4 2025 - EBITDA rebounded to PLN 316.5m, but funding risks and Polyolefins’ conditional sale remain.ATT
Q1 2026 - Q2 EBITDA rebounded, but financing and restructuring risks persist.ATT
Q2 2026 - Q2 EBITDA rebounded to PLN 294m as Chemicals and Agro strengthened.ATT
Q2 2026 - EBITDA surged to PLN 316.5 million as profitability improved and restructuring advanced.ATT
Q1 2026 - EBITDA rebounded on a one-off gain, with revenue up and major restructuring underway.ATT
Q3 2025 - Revenue up 12.4% YoY; Agro leads growth, but net loss persists amid restructuring.ATT
Q1 2025